Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.
Fabris E, Berta B, Hommels T, Roleder T, Hermanides RS, Rivero F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, Pereira B, Magro M, Nef H, Reith S, Roleder-Dylewska M, Gasior P, Malinowski KP, De Luca G, Garcia-Garcia HM, Granada JF, Wojakowski W, Kedhi E. Fabris E, et al. Among authors: granada jf. EuroIntervention. 2023 Feb 6;18(13):e1099-e1107. doi: 10.4244/EIJ-D-22-00306. EuroIntervention. 2023. PMID: 36170036 Free PMC article. Clinical Trial.
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT-FFR Trial.
Fabris E, Berta B, Roleder T, Hermanides RS, IJsselmuiden AJJ, Kauer F, Alfonso F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, Pereira B, Magro M, Nef H, Reith S, Roleder-Dylewska M, Gasior P, Malinowski K, De Luca G, Garcia-Garcia HM, Granada JF, Wojakowski W, Kedhi E. Fabris E, et al. Among authors: granada jf. Circ Cardiovasc Interv. 2022 May;15(5):e011728. doi: 10.1161/CIRCINTERVENTIONS.121.011728. Epub 2022 Apr 29. Circ Cardiovasc Interv. 2022. PMID: 35485232 Free article.
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ, Kauer F, Alfonso F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, Pereira B, Magro M, Nef H, Reith S, Al Nooryani A, Rivero F, Malinowski K, De Luca G, Garcia Garcia H, Granada JF, Wojakowski W. Kedhi E, et al. Among authors: granada jf. Eur Heart J. 2021 Dec 1;42(45):4671-4679. doi: 10.1093/eurheartj/ehab433. Eur Heart J. 2021. PMID: 34345911 Free article. Clinical Trial.
Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT).
Wykrzykowska JJ, Diletti R, Gutierrez-Chico JL, van Geuns RJ, van der Giessen WJ, Ramcharitar S, Duckers HE, Schultz C, de Feyter P, van der Ent M, Regar E, de Jaegere P, Garcia-Garcia HM, Pawar R, Gonzalo N, Ligthart J, de Schepper J, van den Berg N, Milewski K, Granada JF, Serruys PW. Wykrzykowska JJ, et al. Among authors: granada jf. EuroIntervention. 2012 Dec 20;8(8):945-54. doi: 10.4244/EIJV8I8A144. EuroIntervention. 2012. PMID: 22669133 Free article. Clinical Trial.
Safety of Paclitaxel-Coated Balloons in the Coronary Arteries.
Alfonso F, Rivero F, Granada JF. Alfonso F, et al. Among authors: granada jf. J Am Coll Cardiol. 2020 Mar 10;75(9):1029-1032. doi: 10.1016/j.jacc.2019.12.051. J Am Coll Cardiol. 2020. PMID: 32138962 Free article. No abstract available.
Four-year polymer biocompatibility and vascular healing profile of a novel ultrahigh molecular weight amorphous PLLA bioresorbable vascular scaffold: an OCT study in healthy porcine coronary arteries.
Vahl TP, Gasior P, Gongora CA, Ramzipoor K, Lee C, Cheng Y, McGregor J, Shibuya M, Estrada EA, Conditt GB, Kaluza GL, Granada JF. Vahl TP, et al. Among authors: granada jf. EuroIntervention. 2016 Dec 20;12(12):1510-1518. doi: 10.4244/EIJ-D-16-00308. EuroIntervention. 2016. PMID: 27998842 Free article.
Diagnosis and treatment of coronary vulnerable plaques.
García-García HM, Gonzalo N, Granada JF, Regar E, Serruys PW. García-García HM, et al. Among authors: granada jf. Expert Rev Cardiovasc Ther. 2008 Feb;6(2):209-22. doi: 10.1586/14779072.6.2.209. Expert Rev Cardiovasc Ther. 2008. PMID: 18248275 Review.
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
Buszman PP, Milewski K, Pająk J, Jelonek M, Orlik B, Krauze A, Gwiazdowska-Nowotka B, Wojakowski W, Tellez A, Granada JF, Buszman PE. Buszman PP, et al. Among authors: granada jf. EuroIntervention. 2014 Oct;10(6):724-31. doi: 10.4244/EIJV10I6A125. EuroIntervention. 2014. PMID: 24469344 Free article.
Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial.
Żurakowski A, Buszman PP, Milewski KP, Janas A, Gorycki B, Kondys M, Gąsior P, Michalak M, Boxberger M, Peppas A, Granada JF, Buszman PE. Żurakowski A, et al. Among authors: granada jf. J Interv Cardiol. 2015 Aug;28(4):348-57. doi: 10.1111/joic.12210. J Interv Cardiol. 2015. PMID: 26224390 Free article. Clinical Trial.
209 results